Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | -12.32%190.1M | 63.38%216.8M | 78.60%132.7M | -41.73%74.3M | -22.49%127.5M | 49.95%164.5M | 18.08%109.7M | 0.11%92.9M | -26.23%92.8M | 5.98%125.8M |
Other non cash items | ---- | ---- | ---- | -62.64%16.4M | 186.93%43.9M | -57.85%15.3M | 27.37%36.3M | 95.21%28.5M | --14.6M | ---- |
Change In working capital | 297.09%20.3M | 89.89%-10.3M | -266.23%-101.9M | 30.98%61.3M | 331.68%46.8M | -3,940.00%-20.2M | 97.61%-500K | -7,066.67%-20.9M | 101.12%300K | -269.62%-26.8M |
-Change in receivables | 128.26%2.6M | 82.80%-9.2M | -1,673.53%-53.5M | -93.75%3.4M | 1,210.20%54.4M | 86.72%-4.9M | -98.39%-36.9M | ---18.6M | ---- | ---- |
-Change in inventory | 350.00%9.9M | 101.94%2.2M | -623.04%-113.5M | -12.85%21.7M | 220.29%24.9M | -6.70%-20.7M | -117.98%-19.4M | ---8.9M | ---- | ---- |
-Change in other current assets | -102.02%-500K | 549.09%24.7M | -123.11%-5.5M | 237.57%23.8M | -1,061.11%-17.3M | -84.62%1.8M | 248.10%11.7M | ---7.9M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 2.56%216.5M | 367.04%211.1M | -70.36%45.2M | -17.16%152.5M | 29.74%184.1M | 13.07%141.9M | 49.58%125.5M | -11.31%83.9M | -12.89%94.6M | -8.35%108.6M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Capital expenditure reported | -3.81%-92.6M | -96.04%-89.2M | -12.35%-45.5M | 38.07%-40.5M | -58.74%-65.4M | -5.64%-41.2M | -24.60%-39M | 17.85%-31.3M | 28.25%-38.1M | -14.69%-53.1M |
Net PPE purchase and sale | 74.19%5.4M | 158.33%3.1M | 9.09%1.2M | -70.27%1.1M | 42.31%3.7M | 44.44%2.6M | 12.50%1.8M | 45.45%1.6M | -45.00%1.1M | 25.00%2M |
Net business purchase and sale | --0 | 91.99%-3.5M | -3,021.43%-43.7M | 94.59%-1.4M | -2,490.00%-25.9M | ---1M | --0 | 69.32%-7.7M | -7.26%-25.1M | -153.06%-23.4M |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.00%300K | 100.00%600K |
Net other investing changes | ---- | ---- | ---- | ---- | --1.8M | ---- | ---- | ---- | 30.43%-1.6M | -64.29%-2.3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 2.38%-86.2M | -1.49%-88.3M | -125.97%-87M | 55.08%-38.5M | -123.18%-85.7M | -8.17%-38.4M | -0.28%-35.5M | 44.16%-35.4M | 16.14%-63.4M | -18,800.00%-75.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | -65.63%-37.1M | -138.62%-22.4M | 149.07%58M | -677.63%-118.2M | -145.65%-15.2M | 194.69%33.3M | 1,312.50%11.3M | -98.21%800K | 556.12%44.7M | 91.27%-9.8M |
Net common stock issuance | 39.13%-4.2M | -527.27%-6.9M | ---1.1M | --0 | ---- | ---13.4M | --0 | ---- | -940.00%-5.2M | 98.53%-500K |
Cash dividends paid | -4.48%-60.7M | -4.68%-58.1M | -560.71%-55.5M | 84.42%-8.4M | -7.80%-53.9M | -9.65%-50M | -3.87%-45.6M | 0.00%-43.9M | -6.55%-43.9M | -4.57%-41.2M |
Net other financing activities | ---- | ---- | ---- | 127.45%1.4M | -383.33%-5.1M | 117.31%1.8M | -150.49%-10.4M | 428.21%20.6M | -18.75%3.9M | 442.86%4.8M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -21.96%-128.3M | -13,050.00%-105.2M | 99.37%-800K | -65.06%-127.1M | -154.97%-77M | 37.34%-30.2M | -92.80%-48.2M | -509.76%-25M | 91.68%-4.1M | 73.85%-49.3M |
Net cash flow | ||||||||||
Beginning cash position | 10.71%179.8M | -21.47%162.4M | -6.89%206.8M | 4.08%222.1M | 52.43%213.4M | 38.61%140M | 50.75%101M | 74.03%67M | -27.08%38.5M | -57.66%52.8M |
Current changes in cash | -88.64%2M | 141.31%17.6M | -225.19%-42.6M | -161.21%-13.1M | -70.80%21.4M | 75.36%73.3M | 77.87%41.8M | -13.28%23.5M | 266.26%27.1M | 76.85%-16.3M |
Effect of exchange rate changes | -10,400.00%-21M | 88.89%-200K | 18.18%-1.8M | 82.68%-2.2M | -12,800.00%-12.7M | 103.57%100K | -126.67%-2.8M | 650.00%10.5M | -30.00%1.4M | 233.33%2M |
End cash Position | -10.57%160.8M | 10.71%179.8M | -21.47%162.4M | -6.89%206.8M | 4.08%222.1M | 52.43%213.4M | 38.61%140M | 50.75%101M | 74.03%67M | -27.08%38.5M |
Free cash flow | 1.64%123.9M | 40,733.33%121.9M | -100.27%-300K | -5.64%112M | 17.87%118.7M | 16.42%100.7M | 64.45%86.5M | -6.90%52.6M | 1.80%56.5M | -23.13%55.5M |
Currency Unit | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP | GBP |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |